Physician profile
Danielle C Elliott
NPI 1265520035
$570.34
in general payments reported to CMS, 2019-2025
13 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.49 · 2022: $80.80 · 2023: $110 · 2024: $180 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $137.47 | 2021-2025 | Licart, Tirosint, Flector |
| Abbvie INC. | $123.17 | 2023-2025 | |
| Antares Pharma, INC. | $59.89 | 2024-2025 | Xyosted |
| Amneal Pharmaceuticals LLC | $39.75 | 2021-2024 | Unithroid |
| Virtus Pharmaceuticals LLC | $38.27 | 2021 | |
| Novo Nordisk INC | $31.94 | 2022-2024 | Wegovy |
| Lilly USA, LLC | $27.19 | 2021-2025 | Mounjaro |
| Abbott Laboratories | $24.62 | 2024 | Freestyle Libre 3 |
| Philips North America LLC | $20.43 | 2022 | |
| Halozyme INC | $18.77 | 2023 | |
| Scynexis, INC. | $18.68 | 2022 | |
| Daiichi Sankyo INC. | $16.13 | 2022 | |
| Tolmar, INC. | $14.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.